Australia’s ME/CFS Advisory Committee Releases Final Report

Share on facebook
Share on twitter
Share on email

In late 2017, Australia’s National Health and Medical Research Council (NHMRC) – the Australian equivalent of the US National Institutes of Health – established an ME/CFS Advisory Committee to advise NHMRC’s CEO, Professor Anne Kelso, on current needs for research and clinical guidance for ME/CFS in Australia. The committee sat from December 2017 to April 2019.

The final report has been sent to Professor Kelso for her to consider its recommendations. We are waiting to hear her response.

The establishment of this committee was significant for Australia. It not only represented a major step forward in terms of recognition of the disease by our government, but was also the first time that patient advocates had been included in government processes. Two patient advocates sat on the committee: Penelope McMillan and myself, Simone Eyssens.

The committee also represented a significant achievement for ME/CFS advocacy in Australia as it was the culmination of efforts from several organisations and individuals, including ME/CFS South Australia (which wrote the initial submission for a targeted call for research, which led to the establishment of the committee), as well as Emerge Australia, ME Advocacy Network Australia, and others.

Whilst the establishment of the committee was a step forward, it didn’t mean that we were able to release ourselves from the shackles of graded exercise therapy (GET). The committee included some members who use GET in their clinical or research work: Professor Andrew Lloyd, Dr Kathy Rowe and Dr Suzanne Broadbent.

However, NHMRC recognised the need for the ME/CFS community to be heard, and so agreed to undertake a public consultation process as part of this committee’s work, which is something NHMRC usually only does for draft clinical guidelines, not for advisory committees. More than 250 submissions were received, which is amongst the most which NHMRC has ever received during a public consultation process. It is a testament both to community concern and engagement, and the efforts of advocates who ran read alongs and wrote summaries to help patients prepare submissions, that so many submissions were received. Thank you to everyone who wrote a submission. The submissions will be published on NHMRC’s website in the near future (apart from those whose authors asked for theirs not to be made public).

The final report is not perfect but, given the makeup of the committee, it was never going to be exactly what we wanted (especially on the topic of GET). However, the recommendations are forward-looking and, if implemented, would represent significant progress for Australians with ME/CFS. Encouragingly, two of the committee’s recommendations have already been implemented by the Department of Health (based on the draft report):

  • Health economics study.
    This grant was announced in February, and applications closed in April. We are currently waiting to hear the outcome of the grant panel’s review process.
  • $3m targeted call for research (TCR).
    TCRs are very similar to the National Institutes of Health’s Request for Applications, in that they are a grant for a specific topic area, and are designed to stimulate the research field. This was announced in March. The next step in this process would be the announcement of the formation of a TCR committee to formulate the specific focus (within ME/CFS research) for this TCR.
  • A third recommendation from the committee (for the establishment of an ME/CFS biobank) has been implemented by the Mason Foundation (a private Australian foundation which funds ME/CFS and Alzheimer’s research). Mason Foundation began a lengthy process to consider the viability of a biobank prior to the establishment of NHMRC’s Advisory Committee, and this year announced a grant to establish one. Applications for the grant closed on 30 April, and we anticipate an announcement any day.

[maxbutton id=”23″ url=” https://www.nhmrc.gov.au/file/14332/download?token=8q3RRIz6″ text=”Read the Report” ]

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on google
Google+
Share on email
Email

Leave a Comment

Your email address will not be published. Required fields are marked *

Latest News

Sign petition To Fix ME/CFS tracking In US!

In August, we shared with you that we and six other ME/CFS organizations had submitted a proposal to the National Center of Health Statistics (NCHS) to fix the coding of ME/CFS in the US International Classification of Diseases (ICD-10-CM). Today, we are writing with an update on that proposal and asking that you sign the

Read More »

NICE announces roundtable event to ensure implementation of ME/CFS guideline

NICE announced today that it will hold a roundtable in September as the next step in the publication of the ME/CFS guideline. The roundtable will include representatives from patient organisations and charities, relevant professional societies, NHS England and NHS Improvement, NICE and the guideline committee. It aims to, “better understand the issues raised and determine

Read More »

#MEAction & 6 ME Orgs Call for CDC to Change How it Tracks ME/CFS

Together with six other organizations, we have submitted a proposal to the National Center for Health Statistics (NCHS) to add myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) to the neurological chapter of the International Classification of Diseases (ICD-10-CM).  Today, ME/CFS does not exist in the US ICD-10-CM. Instead,  most US doctors assign the code for chronic fatigue

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top